-
Signature
-
/s/ Raphael Deferiere, attorney-in-fact
-
Stock symbol
-
CNTA
-
Transactions as of
-
Oct 27, 2025
-
Transactions value $
-
-$159,950
-
Form type
-
4
-
Date filed
-
10/27/2025, 07:56 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Accardi Mario Alberto |
President, Orexin Program |
C/O CENTESSA PHARMACEUTICALS PLC, 3RD FL., 1 ASHLEY RD, ALTRINCHAM, CHESHIRE, UNITED KINGDOM |
/s/ Raphael Deferiere, attorney-in-fact |
2025-10-27 |
0002074392 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CNTA |
Ordinary Shares |
Options Exercise |
$40.1K |
+5K |
+2.53% |
$8.01 |
202K |
Oct 27, 2025 |
Direct |
F1 |
| transaction |
CNTA |
Ordinary Shares |
Sale |
-$200K |
-8K |
-3.95% |
$25.00 |
194K |
Oct 27, 2025 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CNTA |
Share Option (right to buy) |
Options Exercise |
$0 |
-5K |
-14.29% |
$0.00 |
30K |
Oct 27, 2025 |
Ordinary Shares |
5K |
$8.01 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: